The next generation sequencing market is estimated to have reached $7bn in 2018. Both genetic screening and diagnostic segments dominated the next generation sequencing market in 2018.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Application:

  • Drug Discovery
  • Genetic Screening
  • Diagnostics
  • Personalized Medicine
  • Agriculture and Animal Research
  • Infectious Diseases
  • Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Technology:

  • Whole-Genome Sewuencing
  • Targeted Re-Sequencing
  • Exome Sequencing
  • RNA Seq
  • Chip Seq
  • De Novo Sequencing
  • Methyl Seq
  • Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Product:

  • Instruments
  • Reagents & Consumables
  • Services

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by End User:

  • Hospital & Healthcare Institution
  • Academics
  • Biotechnology
  • Pharmaceutical
  • Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Regional and National Market:

North America

  • US
  • Canada

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Europe

  • Germany
  • The UK
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe


Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN
  • South Korea
  • Rest of Asia-Pacific

MEA

  • GCC Countries
  • Israel
  • Rest of Middle East

Africa

  • South Africa
  • Central Africa
  • North Africa

Each regional market is further segmented by submarkets.

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations:

  • Agilent Technologies, Inc.
  • BGI (Beijing Genomics Institute)
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Illumina, Inc
  • Macrogen, Inc
  • Oxford Nanopore Technologies, Ltd
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc